116 related articles for article (PubMed ID: 1833042)
1. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
[TBL] [Abstract][Full Text] [Related]
3. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.
Bukowski RM; Balcerzak SP; O'Bryan RM; Bonnet JD; Chen TT
Cancer; 1983 Nov; 52(9):1577-82. PubMed ID: 6225508
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
[TBL] [Abstract][Full Text] [Related]
6. Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Dougherty JB; Kelsen D; Kemeny N; Magill G; Botet J; Niedzwiecki D
J Natl Cancer Inst; 1989 Nov; 81(22):1735-8. PubMed ID: 2681796
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Oster MW; Gray R; Panasci L; Perry MC
Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
[TBL] [Abstract][Full Text] [Related]
8. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
Ahmed S; Vaitkevicius VK; Zalupski MM; Du W; Arlauskas P; Gordon C; Kellogg C; Shields AF
Am J Clin Oncol; 2000 Aug; 23(4):420-4. PubMed ID: 10955876
[TBL] [Abstract][Full Text] [Related]
10. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
Cullinan S; Moertel CG; Wieand HS; Schutt AJ; Krook JE; Foley JF; Norris BD; Kardinal CG; Tschetter LK; Barlow JF
Cancer; 1990 May; 65(10):2207-12. PubMed ID: 2189551
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy for advanced pancreatic carcinoma].
Yokoyama T; Shimada Y
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
[TBL] [Abstract][Full Text] [Related]
12. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
Sternberg CN; Magill GB; Sordillo PP; Cheng EW
Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
[TBL] [Abstract][Full Text] [Related]
14. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
[TBL] [Abstract][Full Text] [Related]
15. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
Bruckner HW; Kalman J; Spigelman M; Gorbaty MI; Butwell N; Storch J; McKenna A
Oncology; 1989; 46(6):366-71. PubMed ID: 2511535
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
Moertel CG; Douglas HO; Hanley J; Carbone PP
Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of pancreatic carcinoma.
Zimmerman SE; Smith FP; Schein PS
Cancer; 1981 Mar; 47(6 Suppl):1724-8. PubMed ID: 6456058
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
20. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]